Literature DB >> 23395102

Sarcopenia: prevalence and prognostic significance in hospitalized patients.

Salah Gariballa1, Awad Alessa.   

Abstract

BACKGROUND: Sarcopenia is prevalent in older populations with many causes and varying outcomes however information for use in clinical practice is still lacking. AIMS: The aim of this report is to identify the clinical determinants and prognostic significance of sarcopenia in a cohort of hospitalized acutely ill older patients.
METHODS: Four hundred and thirty two randomly selected patients had their baseline clinical characteristic data assessed within 72 h of admission, at 6 weeks and at 6 months. Nutritional status was assessed from anthropometric and biochemical data. Sarcopenia was diagnosed from low muscle mass and low muscle strength-hand grip using anthropometric measures based on the European Working Group criteria.
RESULTS: Compared with patients without sarcopenia, those diagnosed with sarcopenia 44 (10%) were more likely to be older, have more depression symptoms and lower serum albumin concentration. The length of hospital stay (LOS) was significantly longer in patients diagnosed with sarcopenia compared with patients without sarcopenia [mean (SD) LOS 13.4 (8.8) versus 9.4 (7) days respectively, p = 0.003]. The risk of non-elective readmission in the 6 months follow up period was significantly lower in patients without sarcopenia compared with those diagnosed with sarcopenia (adjusted hazard ratio .53 (95% CI: .32 to .87, p = 0.013). The death rate was also lower in patients without sarcopenia 38/388 (10%), compared with those with sarcopenia 12/44 (27%), p-value = .001.
CONCLUSION: Older people with sarcopenia have poor clinical outcome following acute illness compared with those without sarcopenia.
Copyright © 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Acute illness; Nutrition; Older people; Outcome; Sarcopenia

Mesh:

Year:  2013        PMID: 23395102     DOI: 10.1016/j.clnu.2013.01.010

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  80 in total

1.  Financial impact of sarcopenia on hospitalization costs.

Authors:  A S Sousa; R S Guerra; I Fonseca; F Pichel; S Ferreira; T F Amaral
Journal:  Eur J Clin Nutr       Date:  2016-05-11       Impact factor: 4.016

2.  Incidence, Risk Factors, and the Protective Effect of High Body Mass Index against Sarcopenia in Suburb-Dwelling Elderly Chinese Populations.

Authors:  P Han; J Zhao; Q Guo; J Wang; W Zhang; S Shen; X Wang; R Dong; Y Ma; L Kang; L Fu; L Jia; X Han; Z He; Y Bao; L Wang; K Niu
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

3.  Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.

Authors:  Janet Rodríguez-Torres; Laura López-López; Irene Cabrera-Martos; Gerald Valenza-Demet; Lawrence P Cahalin; Marie Carmen Valenza
Journal:  Support Care Cancer       Date:  2019-04-03       Impact factor: 3.603

4.  Echo intensity is negatively associated with functional capacity in older women.

Authors:  Anderson Rech; Regis Radaelli; Fernanda Reistenbach Goltz; Luis Henrique Telles da Rosa; Cláudia Dornelles Schneider; Ronei Silveira Pinto
Journal:  Age (Dordr)       Date:  2014-08-29

Review 5.  Understanding and reducing disability in older adults following critical illness.

Authors:  Nathan E Brummel; Michele C Balas; Alessandro Morandi; Lauren E Ferrante; Thomas M Gill; E Wesley Ely
Journal:  Crit Care Med       Date:  2015-06       Impact factor: 7.598

6.  Muscle Strength and Muscle Mass in Older Patients during Hospitalization: The EMPOWER Study.

Authors:  Jeanine M Van Ancum; Kira Scheerman; Vincent D Pierik; Siger T Numans; Sjors Verlaan; Hanne E Smeenk; Monique Slee-Valentijn; Roeliene C Kruizinga; Carel G M Meskers; Andrea B Maier
Journal:  Gerontology       Date:  2017-08-18       Impact factor: 5.140

7.  Lower Cognitive Function in Older Patients with Lower Muscle Strength and Muscle Mass.

Authors:  Romee van Dam; Jeanine M Van Ancum; Sjors Verlaan; Kira Scheerman; Carel G M Meskers; Andrea B Maier
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-18       Impact factor: 2.959

Review 8.  Sarcopenia and the Common Mental Disorders: a Potential Regulatory Role of Skeletal Muscle on Brain Function?

Authors:  Julie A Pasco; Lana J Williams; Felice N Jacka; Nicole Stupka; Sharon L Brennan-Olsen; Kara L Holloway; Michael Berk
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

9.  Physical activity, diet quality, and mortality among sarcopenic older adults.

Authors:  Justin C Brown; Michael O Harhay; Meera N Harhay
Journal:  Aging Clin Exp Res       Date:  2016-03-28       Impact factor: 3.636

10.  [Sarcopenia and frailty in older patients with rheumatism].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.